Inventor
Matthias Schneider
Inventor
Dossenheim, DE
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C07KPeptides6%
PatentTitleYear
10,677,795Marker sequences for the diagnosis and stratification of systemic sclerosis patients20209,637,542'CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease'20178,835,441'Heterobicyclic metalloprotease inhibitors'20148,076,330'Dipeptidyl peptidase-IV inhibitors'20117,795,245'Heterobicyclic metalloprotease inhibitors'20107,749,996'Heterotricyclic metalloprotease inhibitors'20107,713,966'Heterobicyclic metalloprotease inhibitors'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2014Based in Dossenheim, DE· patent location history
2011–2017Patents assigned to SCHNEIDER MATTHIAS (3)· patent assignee history
2011–2014Patents assigned to AMGEN INC (2)· patent assignee history
2011–2014Patents assigned to ESSERS MICHAEL (2)· patent assignee history
2011–2014Patents assigned to FEUERSTEIN TIM (2)· patent assignee history
2011–2014Patents assigned to KROTH HEIKO (2)· patent assignee history
2017Based in Bethel, CT, US· patent location history
2020Based in Dusseldorf, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHNEIDER MATTHIASself | 3 | 2011–2017 |
| AMGEN INC | 2 | 2011–2014 |
| ESSERS MICHAEL | 2 | 2011–2014 |
| FEUERSTEIN TIM | 2 | 2011–2014 |
| KROTH HEIKO | 2 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dossenheim, DE | 5 | 2010–2014 |
| Dusseldorf, DE | 1 | 2020 |
| Bethel, CT, US | 1 | 2017 |